Biologists Build Synthetic Cell that Can Feed, Grow, Divide and Evolve
Biologists at the University of Minnesota say they have built a synthetic cell — made entirely from non-living…
HIV can develop resistance to lenacapavir, but at a cost to the virus
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game…